Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-J stent-related lower urinary tract symptoms trial of mirabegron, solifenacin, tamsulosin, tadalafil and their combinations
TCTR20221014002Phase 3Completed
- Sponsor
- Muhammad Asykar Palinrungi
- Start
- Jul 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron, solifenacin, tamsulosin, tadalafil in Micturition disorder, sponsored by Muhammad Asykar Palinrungi. Started Jul 2022; status: completed.
02
Drugs
mirabegronsolifenacintamsulosintadalafil
03
Conditions
Micturition disorder
Beyond the preview
Go deeper on TCTR20221014002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221014002.